These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10518120)

  • 1. Rasagiline, a monoamine oxidase-B inhibitor, protects NGF-differentiated PC12 cells against oxygen-glucose deprivation.
    Abu-Raya S; Blaugrund E; Trembovler V; Shilderman-Bloch E; Shohami E; Lazarovici P
    J Neurosci Res; 1999 Nov; 58(3):456-63. PubMed ID: 10518120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection by NGF in the PC12 in vitro OGD model: involvement of mitogen-activated protein kinases and gene expression.
    Tabakman R; Jiang H; Shahar I; Arien-Zakay H; Levine RA; Lazarovici P
    Ann N Y Acad Sci; 2005 Aug; 1053():84-96. PubMed ID: 16179511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells.
    Abu-Raya S; Tabakman R; Blaugrund E; Trembovler V; Lazarovici P
    Eur J Pharmacol; 2002 Jan; 434(3):109-16. PubMed ID: 11779573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic characteristics of cell death and the neuroprotective effect of homocarnosine on pheochromocytoma PC12 cells exposed to ischemia.
    Tabakman R; Jiang H; Levine RA; Kohen R; Lazarovici P
    J Neurosci Res; 2004 Feb; 75(4):499-507. PubMed ID: 14743433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.
    Guay DR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):330-46. PubMed ID: 17296539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early anesthetic preconditioning in mixed cortical neuronal-glial cell cultures subjected to oxygen-glucose deprivation: the role of adenosine triphosphate dependent potassium channels and reactive oxygen species in sevoflurane-induced neuroprotection.
    Velly LJ; Canas PT; Guillet BA; Labrande CN; Masmejean FM; Nieoullon AL; Gouin FM; Bruder NJ; Pisano PS
    Anesth Analg; 2009 Mar; 108(3):955-63. PubMed ID: 19224809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of carnosine and homocarnosine on pheochromocytoma PC12 cells exposed to ischemia.
    Tabakman R; Lazarovici P; Kohen R
    J Neurosci Res; 2002 May; 68(4):463-9. PubMed ID: 11992473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.
    Youdim MB; Gross A; Finberg JP
    Br J Pharmacol; 2001 Jan; 132(2):500-6. PubMed ID: 11159700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Bcl-2 family of proteins in mediating apoptotic death of PC12 cells exposed to oxygen and glucose deprivation.
    Koubi D; Jiang H; Zhang L; Tang W; Kuo J; Rodriguez AI; Hunter TJ; Seidman MD; Corcoran GB; Levine RA
    Neurochem Int; 2005 Jan; 46(1):73-81. PubMed ID: 15567517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K
    Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rasagiline: a novel anti-Parkinsonian monoamine oxidase-B inhibitor with neuroprotective activity.
    Weinreb O; Amit T; Bar-Am O; Youdim MB
    Prog Neurobiol; 2010 Nov; 92(3):330-44. PubMed ID: 20600573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen-glucose deprivation-induced changes in organotypic cultures of the rat hippocampus.
    Bali B; Nagy Z; Kovács KJ
    Ideggyogy Sz; 2007 Mar; 60(3-4):140-3. PubMed ID: 17451055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DL-3-n-butylphthalide protects endothelial cells against oxidative/nitrosative stress, mitochondrial damage and subsequent cell death after oxygen glucose deprivation in vitro.
    Li L; Zhang B; Tao Y; Wang Y; Wei H; Zhao J; Huang R; Pei Z
    Brain Res; 2009 Sep; 1290():91-101. PubMed ID: 19616517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-Parkinson drug rasagiline and its cholinesterase inhibitor derivatives exert neuroprotection unrelated to MAO inhibition in cell culture and in vivo.
    Youdim MB; Wadia A; Tatton W; Weinstock M
    Ann N Y Acad Sci; 2001 Jun; 939():450-8. PubMed ID: 11462801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual inhibition of protein phosphatase-1/2A and calpain rescues nerve growth factor-differentiated PC12 cells from oxygen-glucose deprivation-induced cell death.
    Nakajima T; Wakasa T; Okuma Y; Inanami O; Nomura Y; Kuwabara M; Kawahara K
    J Neurosci Res; 2006 Feb; 83(3):459-68. PubMed ID: 16385561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of protein kinase C by the anti-Parkinson drug, MAO-B inhibitor, rasagiline and its derivatives, in vivo.
    Bar-Am O; Yogev-Falach M; Amit T; Sagi Y; Youdim MB
    J Neurochem; 2004 Jun; 89(5):1119-25. PubMed ID: 15147504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline.
    Inaba-Hasegawa K; Shamoto-Nagai M; Maruyama W; Naoi M
    J Neural Transm (Vienna); 2017 Sep; 124(9):1055-1066. PubMed ID: 28577058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marine compound Xyloketal B protects PC12 cells against OGD-induced cell damage.
    Zhao J; Li L; Ling C; Li J; Pang JY; Lin YC; Liu J; Huang R; Wang GL; Pei Z; Zeng J
    Brain Res; 2009 Dec; 1302():240-7. PubMed ID: 19765563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs.
    Weinstock M; Kirschbaum-Slager N; Lazarovici P; Bejar C; Youdim MB; Shoham S
    Ann N Y Acad Sci; 2001 Jun; 939():148-61. PubMed ID: 11462767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.